Dengue pre-vaccination screening has been promoted in Puerto Rico to determine eligibility for the dengue vaccine (Dengvaxia), available on the island until March 2025. The screening includes two specific tests: the EUROIMMUN Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG) and the CTK BIOTECH Onsite Dengue IgG. Detection of dengue antibodies in both tests is required to qualify for vaccination.
- Provider:American Academy of Pediatrics
- Activity Link: https://www.praap.org/
- Start Date: 2025-02-08 06:00:00
- End Date: 2025-02-08 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- Commercial Support: No
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest